Pages that link to "Q37384499"
Jump to navigation
Jump to search
The following pages link to Joanne B. Weidhaas (Q37384499):
Displaying 50 items.
- Cancer microRNAs: from subtype profiling to predictors of response to therapy (Q24863739) (← links)
- Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma (Q24595213) (← links)
- MicroRNA signatures differentiate uterine cancer tumor subtypes (Q24633825) (← links)
- A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk (Q24655762) (← links)
- SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer (Q26829794) (← links)
- MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy (Q28259779) (← links)
- MicroRNA in cancer prognosis (Q28304380) (← links)
- The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer (Q28729202) (← links)
- Common variants at 19p13 are associated with susceptibility to ovarian cancer (Q29417145) (← links)
- SNPs in microRNA binding sites as prognostic and predictive cancer biomarkers (Q33640984) (← links)
- Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families (Q33646928) (← links)
- A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer (Q33764182) (← links)
- A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis (Q34030553) (← links)
- A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk (Q34072975) (← links)
- MicroRNA signatures differentiate melanoma subtypes (Q34182764) (← links)
- Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk (Q34621039) (← links)
- MicroRNAs as potential cancer therapeutics. (Q35015730) (← links)
- Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer. (Q35079572) (← links)
- Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice (Q35086711) (← links)
- Tumor-associated mutations in a conserved structural motif alter physical and biochemical properties of human RAD51 recombinase (Q35097983) (← links)
- Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study (Q35112046) (← links)
- The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905 (Q35147597) (← links)
- COX-2 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy and celecoxib: a quantitative immunohistochemical analysis of RTOG C0128 (Q36335351) (← links)
- A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis (Q36369415) (← links)
- Radiation therapy oncology group gynecologic oncology working group: comprehensive results (Q36730351) (← links)
- Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis (Q36868936) (← links)
- The Holman Research Pathway in radiation oncology (Q36916696) (← links)
- miRNA modulation of the cellular stress response (Q37137022) (← links)
- microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis (Q37276128) (← links)
- MicroRNA binding site polymorphisms as biomarkers of cancer risk (Q37320122) (← links)
- Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter (Q37365304) (← links)
- Changes in gene expression predicting local control in cervical cancer: results from Radiation Therapy Oncology Group 0128. (Q37380005) (← links)
- Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases (Q37698895) (← links)
- MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk (Q37833066) (← links)
- Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summa (Q39312730) (← links)
- KRAS alleles: the LCS6 3'UTR variant and KRAS coding sequence mutations in the NCI-60 panel (Q39424345) (← links)
- Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells (Q39452819) (← links)
- A prospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer (Q39608871) (← links)
- The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells (Q39855685) (← links)
- A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer (Q43496062) (← links)
- Breast sentinel lymph node dissection before preoperative chemotherapy. (Q46006632) (← links)
- Using microRNAs to understand cancer biology. (Q55277602) (← links)
- Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer (Q57319395) (← links)
- Retraction to “A 3′ UTR KRAS variant as a biomarker of poor outcome and chemotherapy resistance in ovarian cancer” [Gynecol. Oncol. 120 (2011) S3] (Q57631462) (← links)
- Association between KRAS rs61764370 and triple-negative breast cancer—a false positive? – Authors' reply (Q57631464) (← links)
- KRAS rs61764370 in Epithelial Ovarian Cancer-Letter (Q57631465) (← links)
- Functional microRNA binding site variants (Q60933541) (← links)
- miRNAs in the spotlight: Making 'silent' mutations speak up (Q61965211) (← links)
- Postmastectomy radiation therapy for lymph node‐negative, locally advanced breast cancer after modified radical mastectomy (Q61965242) (← links)
- A Conserved RAS/Mitogen-Activated Protein Kinase Pathway Regulates DNA Damage–Induced Cell Death Postirradiation in Radelegans (Q61965249) (← links)